Alza Makes Another Push For Data In Ditropan Case

Law360, New York (September 21, 2007, 12:00 AM EDT) -- Alza Corp. continues to put pressure on American Sales Co. to produce information that reinforces the plaintiff’s claims that the Johnson & Johnson subsidiary improperly controlled the market for Ditropan XL by preventing the sale of copycat versions of the incontinence drug.

Alza urged the U.S. District Court for the Northern District of California on Thursday to force direct purchaser ASC to hand over the documents, contending that nine months have passed since Alza made its initial discovery requests and ASC has only produced a total...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.